Cardiol Therapeutics, Inc. (CRDL)
2.27
+0.05
(+2.25%)
USD |
NASDAQ |
Sep 09, 14:00
Cardiol Therapeutics Market Cap : 263.06M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 257.26M |
| September 04, 2026 | 254.95M |
| September 03, 2026 | 250.31M |
| September 02, 2026 | 251.47M |
| September 01, 2026 | 249.15M |
| August 31, 2026 | 228.87M |
| August 28, 2026 | 224.82M |
| August 27, 2026 | 238.72M |
| August 26, 2026 | 247.99M |
| August 25, 2026 | 231.77M |
| August 24, 2026 | 215.55M |
| August 21, 2026 | 215.55M |
| August 20, 2026 | 218.44M |
| August 19, 2026 | 227.13M |
| August 18, 2026 | 219.60M |
| August 17, 2026 | 208.59M |
| August 14, 2026 | 208.59M |
| August 13, 2026 | 198.16M |
| August 12, 2026 | 176.14M |
| August 11, 2026 | 173.83M |
| August 10, 2026 | 170.35M |
| August 07, 2026 | 158.86M |
| August 06, 2026 | 152.15M |
| August 05, 2026 | 149.91M |
| August 04, 2026 | 152.15M |
| Date | Value |
|---|---|
| August 03, 2026 | 146.55M |
| July 31, 2026 | 142.08M |
| July 30, 2026 | 135.37M |
| July 29, 2026 | 128.65M |
| July 28, 2026 | 134.25M |
| July 27, 2026 | 129.21M |
| July 24, 2026 | 132.01M |
| July 23, 2026 | 137.60M |
| July 22, 2026 | 143.20M |
| July 21, 2026 | 138.72M |
| July 20, 2026 | 138.16M |
| July 17, 2026 | 135.37M |
| July 16, 2026 | 137.60M |
| July 15, 2026 | 124.18M |
| July 14, 2026 | 128.65M |
| July 13, 2026 | 118.58M |
| July 10, 2026 | 112.99M |
| July 09, 2026 | 110.98M |
| July 08, 2026 | 111.87M |
| July 07, 2026 | 112.99M |
| July 06, 2026 | 119.70M |
| July 02, 2026 | 117.47M |
| July 01, 2026 | 117.47M |
| June 30, 2026 | 118.58M |
| June 29, 2026 | 115.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 4.275M |
| NervGen Pharma Corp. | 230.92M |
| Milestone Pharmaceuticals, Inc. | 134.46M |
| Clearmind Medicine, Inc. | 1.080M |
| Lexaria Bioscience Corp. | 13.01M |
Market Cap Related Metrics
| Price to Book Value | 15.53 |
| Price | 2.27 |
| Earnings Yield | -10.91% |